Charming Medical names Mei Cai independent director, audit committee chair

• Charming Medical named Mei Cai to board as independent director effective May 2, 2026, replacing Matthew Mo Kan Tsui, who resigned effective April 27, 2026 to pursue other business commitments.
• Cai was appointed audit committee chair, with seats on compensation committee, nominating committee.
• She has more than 20 years of experience in accounting, auditing, SEC reporting, corporate finance, US capital markets.
• Most recently served as CFO of Nuance Biotech in 2023, with prior CFO roles at Jowell Global, China Eco-Materials Group.
• She has served as an independent director at Top Financial Group since 2021, with earlier audit roles at Friedman LLP, Patrizio & Zhao.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charming Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-052516), on May 06, 2026, and is solely responsible for the information contained therein.